Indirect effects An indirect pathway for GLP-1RAs to mediate risk for PDAC is via acute or chronic pancreatitis, which are risk factors for PDAC 24,25
Some users also explore microdosing approaches that maintain benefits while reducing side effects
The NEJM paper documents this fall at weeks 36 and 48, while remaining above baseline
Additionally, when comparing Mounjaro vs Ozempic for weight loss, clinical trials suggest that Mounjaro may lead to greater weight reduction
For those with Part D who arent sure of their eligibility for the GLP-1 Bridge Program, please talk to your doctors
A big part of that is understanding how long it remains potent, how to store it properly, and when its time to discard it